Prosecution Insights
Last updated: October 25, 2026

Junhe Law Office P.C.: all pending office actions

← Back to Junhe Law Office P.C.

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19452282 SELECTIVE STENCIL MASK AND A STENCIL PRINTING METHOD Stats Chippac Pte. Ltd. STONER, KILEY SHAWN 1735 §102§103§112 Non-Final OA — Pending Jan 17, 2026
19218586 MEMORY SYSTEM, COMPUTER SYSTEM AND DATA INTERACTION METHOD Montage Technology (Kunshan) Co., Ltd. KORTMAN, CURTIS JAMES 2139 §103§112 Non-Final OA — Pending May 26, 2025
18869848 IMPLANTABLE HEART FAILURE TREATMENT DEVICE UNITED INNOMED (SHANGHAI) LIMITED FAIRCHILD, MALLIKA DIPAYAN 3792 §112 Non-Final OA — Pending Nov 27, 2024
18836758 METHODS FOR TREATING CATARACTS USING POLYPEPTIDES Rejukon Biopharm Inc. KONOPELSKI SNAVEL, SARA ELIZABETH 1658 §102§103§112DP Non-Final OA — Pending Aug 08, 2024
18832936 PHARMACEUTICAL COMPOSITION OF ANTIPLATELET DRUG, AND USE THEREOF Shanghai Curegene Pharmaceutical Co., Ltd. CORNET, JEAN P 1628 §103 Non-Final OA — Pending Jul 25, 2024
18730790 TRUNCATED FORMS OF IGA PROTEASE, FUSION PROTEINS COMPRISING A TRUNCATED FORM OF IGA PROTEASE AND USES THEREOF Shanghai Alezyme Pharmaceuticals Ltd. ROBINSON, HOPE A 1652 §103§112 Non-Final OA — Pending Jul 22, 2024
18725147 METHOD AND DEVICE FOR GENERATING SPEECH ENHANCEMENT MODEL, AND SPEECH ENHANCEMENT METHOD AND DEVICE Orka Health Co., Ltd. HUTCHESON, CODY DOUGLAS 2659 §101§103 Non-Final OA — Pending Jun 28, 2024
18754130 COMBINATION OF BCL-2/BCL-XL INHIBITORS AND CHEMOTHERAPEUTIC AGENT AND USE THEREOF Ascentage Pharma (Suzhou) Co., Ltd. GEMBEH, SHIRLEY V 1615 §103DP Final Rejection — Pending Jun 25, 2024
18749657 SEMICONDUCTOR PACAKGE AND METHOD FOR FORMING THE SAME Stats Chippac Pte. Ltd. STARK, JARRETT J 2898 §103§112 Non-Final OA — Pending Jun 21, 2024
18749572 DENTAL APPLIANCE SYSTEM AND AN ORTHODONTIC METHOD USING THE SAME Wuxi Ea Medical Instruments Technologies Limited NELSON, MATTHEW M 3772 §101§102 Final Rejection — Pending Jun 20, 2024
18740630 SEMICONDUCTOR PACKAGES WITH MULTIPLE TYPES OF CONDUCTIVE COMPONENTS Stats Chippac Pte. Ltd. SENGDARA, VONGSAVANH 2893 §102§103 Non-Final OA — Pending Jun 12, 2024
18731402 Chimeric Natural Killer Cell Receptors and Method of Using Thereof St Phi Therapeutics Co., Ltd. KAUFMAN, CLAIRE M 1674 §103 Final Rejection 37d overdue Pending Jun 03, 2024
18670747 SEMICONDUCTOR PACKAGE WITH IMPROVED HEAT DISSIPATION Jcet Stats Chippac Korea Limited WIEGAND, TYLER J 2812 §102§112 Non-Final OA — Pending May 22, 2024
18709820 COMPOUND FOR REDUCING URIC ACID LEVELS Newsoara Biopharma Co., Ltd. BRAUN, MADELINE E 1624 §103§112 Final Rejection — Pending May 14, 2024
18661773 ELECTRONIC PACKAGE AND METHOD FOR FORMING THE SAME Stats Chippac Pte. Ltd. HOQUE, MOHAMMAD M 2817 §112 Non-Final OA — Pending May 13, 2024
18655254 ELECTRONIC PACKAGE AND A PACKAGING METHOD Stats Chippac Pte. Ltd. HARBOTTLE, CHARLOTTE ELIZABETH 2818 §103§112 Non-Final OA — Pending May 04, 2024
18646903 SEMICONDUCTOR DEVICE AND METHOD FOR MAKING THE SAME Stats Chippac Pte. Ltd. THROCKMORTON, ROBERT EMIL 2818 §102§103 Non-Final OA — Pending Apr 26, 2024
18639994 SEMICONDUCTOR DEVICE WITH A PARTIAL SHIELDING LAYER AND A METHOD FOR MAKING THE SAME Jcet Stats Chippac Korea Limited MUNOZ, ANDRES F 2818 §103 Non-Final OA — Pending Apr 19, 2024
18638733 SEMICONDUCTOR DEVICE AND A METHOD FOR FORMING A SEMICONDUCTOR DEVICE Stats Chippac Pte. Ltd. TRAN, DZUNG 2893 §103 Non-Final OA — Pending Apr 18, 2024
18636301 SEMICONDUCTOR PACKAGE STRIP AND METHOD FOR FORMING A SEMICONDUCTOR DEVICE Jcet Stats Chippac Korea Limited TURNER, BRIAN 2818 §102§103 Final Rejection — Pending Apr 16, 2024
18700268 METHODS FOR DEVELOPING A CELL LINE FOR PRODUCING VIRUS IN SUSPENSION CELL CULTURE Porton Advanced Solutions Ltd. KIM, TAEYOON 1631 §103§112 Non-Final OA — Pending Apr 10, 2024
18697015 HALOGENATED PHENYLARSINE OXIDE COMPOUND AND APPLICATION THEREOF Nuo-Beta Pharmaceutical Technology (Shanghai) Co., Ltd. HABTE, KAHSAY 1624 §102§112DP Non-Final OA — Pending Mar 29, 2024
18605841 INTEGRATED PACKAGE AND METHOD FOR MAKING THE SAME Stats Chippac Pte. Ltd. MALSAWMA, LALRINFAMKIM HMAR 2892 §103 Non-Final OA — Pending Mar 15, 2024
18692340 DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF Coval Biopharma (Shanghai) Co., Ltd. SHIAO, YIH-HORNG §102§103Other Non-Final OA — Pending Mar 15, 2024
18605842 PARTIALLY SHIELDED SEMICONDUCTOR DEVICE AND METHOD FOR MAKING THE SAME Stats Chippac Pte. Ltd. MALSAWMA, LALRINFAMKIM HMAR 2892 §102§103 Non-Final OA — Pending Mar 15, 2024
18597878 SEMICONDUCTOR DEVICE WITH IMPROVED HEAT DISSIPATION AND METHOD FOR MAKING THE SAME Jcet Stats Chippac Korea Limited MAZUMDER, DIDARUL A 2812 §103 Final Rejection — Pending Mar 06, 2024
18292922 NOVEL ANTI-SIRPA ANTIBODIES Elpiscience Biopharma, Ltd. LANDSMAN, ROBERT S 1647 §112 Non-Final OA — Pending Jan 28, 2024
18292921 NOVEL MULTI-SPECIFIC MOLECULES Elpiscience Biopharma, Ltd. REDDIG, PETER J §102§103§112Other Non-Final OA — Pending Jan 28, 2024
18575326 NOVEL ANTI-MASP-2 ANTIBODIES Suzhou Transcenta Therapeutics Co., Ltd. STOICA, ELLY GERALD 1647 §112 Non-Final OA — Pending Dec 29, 2023
18395626 SEMICONDUCTOR DEVICE AND METHOD FOR MAKING THE SAME Stats Chippac Pte. Ltd. NGUYEN, SOPHIA T 2893 §103§112 Final Rejection — Pending Dec 25, 2023
18395650 ELECTRONIC DEVICE AND METHOD FOR MANUFACTURING THE SAME Jcet Stats Chippac Korea Limited TRAN, TAN N 2812 §103 Final Rejection — Pending Dec 25, 2023
18559795 NOVEL ANTI-CD276 ANTIBODIES AND THE USES THEREOF Antengene Biologics Limited MOSELEY II, NELSON B 1642 §112 Non-Final OA — Pending Nov 09, 2023
18556665 HETERODIMERIC ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF Chimagen Biosciences, Ltd. CUNNINGCHEN, KATHLEEN MARY 1646 §102§103§112 Non-Final OA — Pending Oct 21, 2023
18555341 NOVEL ANTI-HVEGFR2 ANTIBODIES Suzhou Transcenta Therapeutics Co., Ltd. BALLARD, KIMBERLY 1675 §112 Non-Final OA — Pending Oct 13, 2023
18469536 METHOD FOR MAKING AN ELECTRONIC PACKAGE Jcet Stats Chippac Korea Limited NETTLES, CORALIE ANN 2893 §103 Non-Final OA 22d Pending Sep 18, 2023
18549928 METHOD OF TREATING DISEASES USING GREMLIN1 ANTAGONISTS Suzhou Transcenta Therapeutics Co., Ltd. BELYAVSKYI, MICHAIL A 1644 §103DP Final Rejection — Pending Sep 11, 2023
18460621 SEMICONDUCTOR DEVICE AND METHOD FOR MAKING THE SAME Stats Chippac Pte. Ltd. FAN, SU JYA 2818 §103 Final Rejection — Pending Sep 04, 2023
18459014 SENSOR ASSEMBLY AND METHOD FOR FORMING THE SAME Stats Chippac Pte. Ltd. KUPP, BENJAMIN MICHAEL 2893 §103 Final Rejection 7d Pending Aug 30, 2023
18546980 ANTI-CLDN18.2 ANTIBODY CONJUGATES BEIJING CANCER HOSPITAL DUNN, LINDSAY MICHELLE 1644 §102§103§112DP Non-Final OA — Pending Aug 18, 2023
18447315 SEMICONDUCTOR DEVICES WITH PYRAMIDAL SHIELDING AND METHOD FOR MAKING THE SAME Stats Chippac Pte. Ltd. BULLARD-CONNOR, GENEVIEVE GRACE 2899 §103 Final Rejection 9d Pending Aug 10, 2023
18264765 METHODS OF MODULATING ANDROGEN RECEPTOR CONDENSATES Etern Therapeutics (Wuxi) Co., Ltd. BELL, SARA ELIZABETH 1625 §102§103§112 Non-Final OA — Pending Aug 09, 2023
18264764 METHODS FOR MODULATING A SRC-1 CONDENSATE Etern Therapeutics Inc. BERKE-SCHLESSEL, DAVID W 1651 §101§102§103§112 Non-Final OA — Pending Aug 09, 2023
18263088 APPARATUS AND SYSTEMS FOR MONITORING AND TREATING CATARACTS Edinburgh Biosciences Ltd. FABIAN JR, ROBERTO 2877 §103 Non-Final OA 33d Pending Jul 26, 2023
18353863 ELECTRONIC COMPONENTS WITH IMPROVED INSULATION, ELECTRONIC PACKAGES INCORPORATING SUCH ELECTRONIC COMPONENTS Stats Chippac Pte. Ltd. MELLINGER, CORBYN DAVID 2899 §102§112 Non-Final OA — Pending Jul 17, 2023
18338313 NOVEL METHOD FOR PRODUCING ANTIBODIES Tsinghua University NATARAJAN, MEERA 1643 §103 Non-Final OA — Pending Jun 20, 2023
18254606 NOVEL CONJUGATE MOLECULES TARGETING CD39 AND TGFBETA Elpiscience Biopharma, Ltd. HADDAD, MAHER M 1641 §102 Final Rejection — Pending May 26, 2023
18246516 NOVEL ANTI-CLAUDIN18 ANTIBODIES Elpiscience Biopharma, Ltd. BERHANE, SELAM 1675 §112 Final Rejection 62d Pending Mar 24, 2023
18172322 METHODS FOR DETECTING HOMOLOGOUS RECOMBINATION DEFICIENCY IN CANCER PATIENTS Genegeniedx Corp. HAYES, JONATHAN EDWARD 1685 §101§103§112 Non-Final OA — Pending Feb 22, 2023
18005356 DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF Coval Biopharma (Shanghai) Co., Ltd. BRANDSEN, BENJAMIN MICHAEL 1693 §103§112Other Final Rejection — Pending Jan 13, 2023
17624850 MICROMOLECULE PI4KIIIalpha INHIBITOR COMPOSITION, PREPARATION METHOD THEREFOR AND USE THEREOF Nuo-Beta Pharmaceutical Technology (Shanghaia) Co., Ltd. YOUNGBLOOD, WILLIAM JUSTIN 1629 §103Other Final Rejection — Pending Nov 18, 2022
18050476 METHODS FOR SCREENING VARIANT OF TARGET GENE Applied Stemcell, Inc. BOESEN, CHRISTIAN C 1684 DP Final Rejection — Pending Oct 28, 2022
17918557 NOVEL MEDICAL USE OF MDM2 INHIBITORS Ascentage Pharma Group Corp Limited NOLAN, JASON MICHAEL 1600 §103DP Final Rejection — Pending Oct 12, 2022
17885578 ERBB RECEPTOR INHIBITORS Dizal (Jiangsu) Pharmaceutical Co., Ltd. HIRAKIS, SOPHIA P 1623 §112 Non-Final OA 23d overdue Pending Aug 11, 2022
17761602 ATOMIZER Suzhou Skywell Healthcare Information Co., Ltd. LEBRON DE JESUS, GRACIELA NATALIA 3785 §103 Final Rejection — Pending Mar 18, 2022
16918958 HIGH CAPACITY MOLECULE DETECTION Davinci Bio, Inc. POHNERT, STEVEN C 1683 §102§103§112 Final Rejection 202d overdue Pending Jul 01, 2020

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month